16 March 2023Large-scale quantitative phase imaging-based single-cell morphological profiling of chemical and genetic perturbations (Conference Presentation)
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
We developed a large-scale single-cell intrinsic morphological profiling strategy using ultrahigh-throughput quantitative phase imaging (QPI) combined with a novel spinning on-the-fly cell-based assay platform. This integrated system demonstrates the unprecedented functional assay capability of QPI in not only scaling up the assay throughput, but also empowering new cytometric power to perform multiplexed live-cell drug screening (96 conditions in a single run) and genetic perturbation assay (by CRISPR). This platform thus allows generation of large cellular QPI datasets (4.85 TByte in this study) that could spearhead cost-effective label-free solutions for identifying disease-or gene-related cellular morphological phenotypes in therapeutics screening.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Dickson Siu, Victor M. L. Wong, Sum Lau, Bei Wang, Alan S. L. Wong, Kenneth K. Y. Wong, Kevin K. Tsia, "Large-scale quantitative phase imaging-based single-cell morphological profiling of chemical and genetic perturbations (Conference Presentation)," Proc. SPIE PC12389, Quantitative Phase Imaging IX, PC123890V (16 March 2023); https://doi.org/10.1117/12.2655441